Sg Americas Securities, LLC Gossamer Bio, Inc. Transaction History

Sg Americas Securities, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$0.8 - $1.51 $22,816 - $43,065	28,520 New	28,520 $34,000
Q1 2023 Apr 28, 2023	BUY	$0.96 - $2.92 $160,095 - $486,956	166,766 New	166,766 $210,000
Q3 2022 Oct 31, 2022	SELL	$7.21 - $14.88 $106,462 - $219,718	-14,766 Reduced 51.87%	13,701 $164,000
Q2 2022 Jul 29, 2022	BUY	$5.97 - $9.97 $84,612 - $141,304	14,173 Added 99.15%	28,467 $238,000
Q1 2022 Apr 29, 2022	SELL	$8.44 - $12.49 $51,770 - $76,613	-6,134 Reduced 30.03%	14,294 $124,000
Q4 2021 Feb 07, 2022	SELL	$10.12 - $14.07 $287,266 - $399,391	-28,386 Reduced 58.15%	20,428 $231,000
Q3 2021 Nov 01, 2021	BUY	$7.25 - $13.23 $353,901 - $645,809	48,814 New	48,814 $614,000
Q2 2021 Aug 12, 2021	SELL	$8.0 - $9.75 $102,120 - $124,458	-12,765 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$8.63 - $10.94 $110,161 - $139,649	12,765 New	12,765 $118,000
Q4 2020 Feb 04, 2021	SELL	$8.3 - $13.59 $208,255 - $340,986	-25,091 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$11.3 - $14.75 $336,751 - $439,564	-29,801 Reduced 54.29%	25,091 $311,000
Q2 2020 Jul 20, 2020	BUY	$9.52 - $15.98 $522,571 - $877,174	54,892 New	54,892 $714,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $93M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.